Biocomp gradient station instrument system, for both formation and fractionation of gradients, in support of the NCI, CCR, BG

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600043A
Awardee
Awarding agency
Obligated
$30,236

Award facts

Contract value 100% obligated
$30,236.47 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $30,236

About this award

The National Cancer Institute awarded a purchase order to Biocomp Instruments Inc. for $30,236.47 on September 22, 2016, for a biocomp gradient station instrument system supporting formation and fractionation of gradients for the NCI Center for Cancer Research. Work is performed at 2323 Riverside Drive, Ottawa, Ontario, Canada. The order is firm fixed price with an ultimate completion date of November 21, 2016.

Quick answers

Who was awarded contract HHSN261201600043A?

HHSN261201600043A was awarded to Biocomp Instruments Inc. by National Cancer Institute (National Institutes of Health) on September 22, 2016.

How much is contract HHSN261201600043A worth?

The government has obligated $30,236 on HHSN261201600043A.

Was contract HHSN261201600043A competed?

The extent of competition for HHSN261201600043A was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award